MIT Implant Monitors for Cancer and Heart Attacks
The sensor consists of a reservoir containing MRSw particles enclosed by a size-exclusion membrane. T2 changes are produced when analytes diffuse across the membrane and initiate particle aggregation. During about 30 percent of all heart attacks, the patient experiences no symptoms. However, unmistakable signs of the attack remain in the bloodstream for days. MIT researchers, …